Listen Score
LS 27
Global Rank
TOP 10%

MENGENAI PODCAST INI 🔗

Kekerapan kemas kini:
semiweekly
Purata panjang audio:
33 minutes
Mempunyai penaja
Bahasa Inggeris
Amerika Syarikat
633 episod
sejak 28 Jun 2019
episodic

AUDIENCE OF THIS PODCAST 🔗

~64.60% of listeners are from India.
🇮🇳
IN
64.60%
🇺🇸
US
28.35%
🇩🇪
DE
1.70%
🇦🇺
AU
1.27%
🇦🇷
AR
0.63%
🇨🇦
CA
0.63%
🇬🇧
GB
0.42%
🇦🇪
AE
0.42%
🇵🇭
PH
0.42%
🇩🇰
DK
0.21%
🇪🇬
EG
0.21%
🇹🇿
TZ
0.21%
🇹🇼
TW
0.21%
🇸🇦
SA
0.21%
🇨🇱
CL
0.21%
🇩🇿
DZ
0.21%
Others
0.09%
* Data source: directly measured on Listen Notes. masa nyata

EPISOD TERKINI 🔗

Using real-world patient case examples, hear from expert faculty on how they would navigate treatment choices using the latest data for patients with ATTR-CM. Credit available for this activity expires: 10/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewa ...

CARI EPISOD LEPAS

Cari episod lepas bagi Keeping Current.

EPISOD SEBELUMNYA

A molecular clock is ticking in your patients with metastatic breast cancer. Are you listening? Credit available for this activity expires: 10/12/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/frontiers-modern-oncology-molecular-guided-strategies-hr ...
Discover how novel therapies and expert consensus on the KDIGO framework are revolutionizing IgAN management to slow disease progression. Credit available for this activity expires: 10/13/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-iga ...
ADCs are moving from the metastatic setting into curative-intent neoadjuvant and adjuvant lines of treatment. Are you ready? Credit available for this activity expires: 10/5/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/antibody-drug-conjugate-the ...
Do you know who to test, when to test, and which biomarker test to use? Credit available for this activity expires: 9/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/solving-alzheimers-disease-biomarker-puzzle-live-european-2026a1000y9g?ecd=bdc_po ...
Do you know how to meet the challenges of treating uveitic macular edema? Credit available for this activity expires: 9/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-uveitic-macular-edema-management-whats-new-2026a1000y92?ecd=bdc_podca ...
Move beyond supportive care with targeted therapies for immunoglobulin A nephropathy (IgAN) management. Credit available for this activity expires: 09/24/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-journeys-iga-nephropathy-optimizing-ou ...
How can adjuvant therapy be optimally individualized? What tools and insights are required? Join us to learn more. Credit available for this activity expires: 09/21/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/refining-adjuvant-therapy-hr-positi ...
Can CAR T-cell therapies achieve drug-free remission in severe refractory autoimmune diseases? Credit available for this activity expires: 9/22/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-journey-severe-refractory-autoimmune-rheumatic-202 ...
Are you up to speed on the latest updates on molecular-guided therapies in HR-positive/HER2-negative metastatic breast cancer (MBC)? Join us to learn more. Credit available for this activity expires: 9/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewartic ...
Penafian: Podcast dan karya seni yang dibenamkan pada halaman ini adalah daripada Medscape Podcasts, yang merupakan hak milik pemiliknya dan tidak bergabung dengan atau disokong oleh Listen Notes, Inc.